{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:29:34Z","timestamp":1792783774924,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"science & technology department of Heilongjiang province, China","award":["12521210"],"award-info":[{"award-number":["12521210"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.biopha.2017.02.090","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T15:40:38Z","timestamp":1489506038000},"page":"1178-1186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":174,"special_numbering":"C","title":["LncRNA MEG3 inhibited osteogenic differentiation of bone marrow mesenchymal stem cells from postmenopausal osteoporosis by targeting miR-133a-3p"],"prefix":"10.1016","volume":"89","author":[{"given":"Qiujun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yina","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.biopha.2017.02.090_bib0005","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1080\/14656566.2016.1176147","article-title":"Treatment needs and current options for postmenopausal osteoporosis","volume":"17","author":"Gennari","year":"2016","journal-title":"Expert Opin. Pharmacother."},{"issue":"3","key":"10.1016\/j.biopha.2017.02.090_bib0010","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMcp1513724","article-title":"Clinical practice. Postmenopausal osteoporosis","volume":"374","author":"Black","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.biopha.2017.02.090_bib0015","first-page":"213","article-title":"Hormone replacement therapy and the prevention of postmenopausal osteoporosis","volume":"13","author":"Gambacciani","year":"2014","journal-title":"Prz. Menopauzalny"},{"issue":"3","key":"10.1016\/j.biopha.2017.02.090_bib0020","first-page":"181","article-title":"Osteoporosis management in post-menopausal women","volume":"64","author":"Christenson","year":"2012","journal-title":"Minerva Ginecol."},{"issue":"3","key":"10.1016\/j.biopha.2017.02.090_bib0025","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1902\/jop.2002.73.3.298","article-title":"Relationships between clinical attachment level and spine and hip bone mineral density: data from healthy postmenopausal women","volume":"73","author":"Pilgram","year":"2002","journal-title":"J. Periodontol."},{"issue":"4","key":"10.1016\/j.biopha.2017.02.090_bib0030","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/1097-4644(20001215)79:4<557::AID-JCB40>3.0.CO;2-H","article-title":"Mesenchymal stem cells from osteoporotic patients produce a type I collagen-deficient extracellular matrix favoring adipogenic differentiation","volume":"79","author":"Rodriguez","year":"2000","journal-title":"J. Cell. Biochem."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2017.02.090_bib0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11010-014-2021-7","article-title":"Estrogen improves the proliferation and differentiation of hBMSCs derived from postmenopausal osteoporosis through notch signaling pathway","volume":"392","author":"Fan","year":"2014","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.biopha.2017.02.090_bib0040","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.2909","article-title":"A novel, direct no donor regulates osteoblast and osteoclast functions and increases bone mass in ovariectomized mice","volume":"32","author":"Kalyanaraman","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.biopha.2017.02.090_bib0045","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000445621","article-title":"MiR-27a is essential for the shift from osteogenic differentiation to adipogenic differentiation of mesenchymal stem cells in postmenopausal osteoporosis","volume":"39","author":"You","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2017.02.090_bib0050","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1074\/jbc.M116.750950","article-title":"MEG3 long noncoding RNA contributes to the epigenetic regulation of epithelial-mesenchymal transition in lung cancer cell lines","volume":"292","author":"Terashima","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2017.02.090_bib0055","first-page":"1","article-title":"The long non-coding RNA maternally expressed gene 3 activates p53 and is downregulated in esophageal squamous cell cancer","author":"Lv","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.biopha.2017.02.090_bib0060","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/1471-2407-14-495","article-title":"Epigenetic silencing of genes and microRNAs within the imprinted Dlk1-Dio3 region at human chromosome 14.32 in giant cell tumor of bone","volume":"14","author":"Lehner","year":"2014","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2017.02.090_bib0065","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/stem.1989","article-title":"Upregulation of lncRNA MEG3 promotes osteogenic differentiation of mesenchymal stem cells from multiple myeloma patients by targeting BMP4 transcription","volume":"33","author":"Zhuang","year":"2015","journal-title":"Stem Cells (Dayton, Ohio)"},{"issue":"1","key":"10.1016\/j.biopha.2017.02.090_bib0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/10409238.2012.738643","article-title":"MicroRNA biogenesis: regulating the regulators","volume":"48","author":"Finnegan","year":"2013","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2017.02.090_bib0075","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.eururo.2011.01.044","article-title":"MicroRNA in prostate, bladder, and kidney cancer: a systematic review","volume":"59","author":"Catto","year":"2011","journal-title":"Eur. Urol."},{"issue":"2 (Jan 10)","key":"10.1016\/j.biopha.2017.02.090_bib0080","first-page":"3666","article-title":"miRNAs in acute myeloid leukemia","volume":"8","author":"Liao","year":"2016","journal-title":"Oncotarget"},{"issue":"37","key":"10.1016\/j.biopha.2017.02.090_bib0085","doi-asserted-by":"crossref","first-page":"13906","DOI":"10.1073\/pnas.0804438105","article-title":"A microRNA signature for a BMP2-induced osteoblast lineage commitment program","volume":"105","author":"Li","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2017.02.090_bib0090","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.12659\/MSM.894323","article-title":"MiR-133 is involved in estrogen deficiency-induced osteoporosis through modulating osteogenic differentiation of mesenchymal stem cells","volume":"21","author":"Lv","year":"2015","journal-title":"Med. Sci. Monit."},{"issue":"4","key":"10.1016\/j.biopha.2017.02.090_bib0095","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1159\/000443074","article-title":"Changes in the MicroRNA profile of the mandible of ovariectomized mice","volume":"38","author":"Hao","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"issue":"3","key":"10.1016\/j.biopha.2017.02.090_bib0100","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/cr.2012.164","article-title":"The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage","volume":"23","author":"Zhang","year":"2012","journal-title":"Cell Res."},{"key":"10.1016\/j.biopha.2017.02.090_bib0105","doi-asserted-by":"crossref","first-page":"16069","DOI":"10.1038\/nrdp.2016.69","article-title":"Postmenopausal osteoporosis","volume":"2","author":"Eastell","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.biopha.2017.02.090_bib0110","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12906-015-0777-2","article-title":"Effect of Qing\u2019e formula on the in vitro differentiation of bone marrow-derived mesenchymal stem cells from proximal femurs of postmenopausal osteoporotic mice","volume":"15","author":"Shuai","year":"2015","journal-title":"BMC Complement. Altern. Med."},{"issue":"3","key":"10.1016\/j.biopha.2017.02.090_bib0115","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00198-013-2494-3","article-title":"Osteoanabolic effect of alendronate and zoledronate on bone marrow stromal cells (BMSCs) isolated from aged female osteoporotic patients and its implications for their mode of action in the treatment of age-related bone loss","volume":"25","author":"Lindtner","year":"2014","journal-title":"Osteoporos. Int."},{"issue":"4","key":"10.1016\/j.biopha.2017.02.090_bib0120","doi-asserted-by":"crossref","first-page":"e34641","DOI":"10.1371\/journal.pone.0034641","article-title":"MiR-133a in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216327408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216327408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:18:32Z","timestamp":1760095112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216327408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":24,"alternative-id":["S0753332216327408"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.02.090","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LncRNA MEG3 inhibited osteogenic differentiation of bone marrow mesenchymal stem cells from postmenopausal osteoporosis by targeting miR-133a-3p","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.02.090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}